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to Promote Primary Care Based 




Dr. Cornelius Ferreira MD and Kathy McCoy APRN
What is Diabetic 
Retinopathy
 Diabetic retinopathy is a disease that causes damage to 
the eyes as a result of chronic hyperglycemia. The 
disease is categorized into two types:
 Proliferative diabetic retinopathy involves the 
pathologic proliferation of blood vessels in the eye 
which can cause preretinal and vitreous 
hemorrhage, fibrosis and retinal detachment
 Nonproliferative diabetic retinopathy involves 
nerve-fiber infarcts, which cause cotton wool 
spots, microvascular abnormalities, and hard 
exudates
 Macular edema, defined by retinal thickening and 
swelling of the macula, can happen at any point in 
disease and also leads to vision loss1
The Problem:
 Diabetic retinopathy is the leading cause of blindness in people age 25-74 in the 
world 1
 It has an insidious onset, and when patient’s become symptomatic, it’s often too 
late to intervene
 On average only 60% of diabetic patient’s receive an annual eye exam and in 
underserved areas that can drop to 25% 2
 2% of patient’s with existing diabetic retinopathy with progress to blindness every 
year 3
 The prevalence of vision loss from diabetes has risen by nearly 2/3 in the past 2 
decades, in 2010 833,690 people were blind as a result of DR and 3.7 million were 
visually impaired 4
 In the Western Connecticut Health Network (WCHN) only 32% of diabetic patient’s 
have had a documented eye exam in the past year. 3
Economics
 Annual total cost of blindness per person is 
estimated to be $18,670 5
 Annual direct cost of eye related care for a 
blind patient is approximately $4443 6
 Total annual medical expenditure related to 
blindness in USA is $8,102,000,000 7
 The cost of a community based diabetic 
screening is approximately $116 8
 The cost of diabetic retinopathy referral was 
$478 (24.4% of patients referred with diabetic 
retinopathy) 8
Community Perspective
 Dr. Ferreira of Brookfield Family Medicine (part of WCHN) had this to say: 
 “Historically our practice has not referred patients for diabetic eye exams. We’ve always 
educated patient’s about the importance of the exam and told them to see the eye doctor 
on their own. Unfortunately there is no way to verify if they went or not.”
 This will change in January when his practice begins a new telemedicine screening 
program in which patients can get their screening done in the office using IRIS teleretinal
technology. During this 5 minute exam the machine takes a detailed image of the patient’s 
retina and sends it to Ophthalmologists at the Mayo Clinic for analysis. Should signs of 
diabetic retinopathy be found, patients are then referred to ophthalmology.
 Dr. Ferriera believes that the key to this screening program’s success will be educating 
patient’s about the dangers of diabetic retinopathy and the importance of screening.
 A Danbury CT Ophthalmologist commented that she believed doctors in her 
community were doing very well with referring patient’s for diabetic eye exams. She 
felt that the biggest barrier to care was lack of health insurance in patients under 
65. She was enthusiastic about the new telemedicine screening at Brookfield Family 
Medicine, but cautioned that this screening was only part of the care necessary, and 
that in person screening for retinopathy is always superior.
Intelligent Retinal Imaging 
System (IRIS) Machine
Intervention and Methodology
 A patient handout was created to educate patient’s about 
diabetic retinopathy
 This handout emphasized the prevalence of diabetic 
retinopathy, the insidious onset of the disease and the 
importance of screening
 The handout also included details about the new 
telemedicine screening program at Brookfield Family 
Medicine, encouraging patients to learn more about and 
consider participating in the screening
Results
 The patient education pamphlet was distributed to a few patients and 
preliminary responses included:
 “This is very good…I knew eye exams were important, but I never realized why 
before…I’m going to the eye doctor now…My daughter needs to know about this…”
 Ideally this pamphlet will both serve to educate patients who were unaware 
of the dangers of diabetic retinopathy and encourage those already aware to 
get their annual screening
 The long term goal of this pamphlet is to inform and encourage patients to 
take advantage of the new, convenient and inexpensive primary care based 
diabetic retinopathy screening program at Brookfield Family Medicine
Limitations
 This intervention was done in only one family medicine practice, so it was 
impossible to assess the effectiveness across a more diverse patient 
population
 Additionally given time constraints, only a few patients were able to see the 
pamphlets and provide feedback
 Furthermore longitudinal follow up to assess patient compliance with 
screening was also not possible given time constraints 
Future Directions
 A quality control study could be conducted in a longitudinal manner to assess 
whether patients were more inclined to get diabetic retinopathy screening 
after viewing the pamphlet
 This pamphlet could be made available in all 16 Western Connecticut Medical 
Group primary care practices, thus dramatically increasing its impact and 
potential sample size
 Further study opportunities are available with the advent of the primary care 
based teleretinal screening program in January
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